You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cell Growth Inhibitors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Cell Carcinoma, Colorectal Cancer, Non Small Cell Lung Cancer Trial in Lyon (Cicaplast Balm B5, Dexeryl)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • +3 more
  • Cicaplast Balm B5
  • Dexeryl
  • Lyon, Rhône, France
    Centre Léon Bérard
Jul 8, 2021

Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular

Completed
  • AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs
  • Wenzhou, Zhejiang, China
    The First Affiliated Hospital of Wenzhou Medical University
Nov 6, 2023

Acute Esophageal Variceal Hemorrhage Trial in Hanzhou (Growth Inhibitor)

Recruiting
  • Acute Esophageal Variceal Hemorrhage
  • Growth Inhibitor
  • Hanzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Aug 22, 2023

Tumor Growth Rate Predicts Clinical Outcomes for Advanced

Recruiting
  • Non-Small Cell Lung Cancer
  • This item is not applicable to our observational study.
  • Guangzhou, Guangdong, China
  • +2 more
Mar 15, 2021

NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in United States (furmonertinib 240 mg, furmonertinib 160 mg, platinum-based chemo)

Recruiting
  • Non-Small Cell Lung Cancer
  • +13 more
  • furmonertinib 240 mg
  • +2 more
  • Yuma, Arizona
  • +37 more
Dec 14, 2022

EGFR Mutant Advanced Non Small Cell Lung Cancer Trial in Australia, Taiwan (Tremelimumab, Durvalumab)

Recruiting
  • EGFR Mutant Advanced Non Small Cell Lung Cancer
  • Bankstown, New South Wales, Australia
  • +17 more
Sep 28, 2021

ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced

Completed
  • NSCLC
  • Immune checkpoint inhibitors plus angiogenesis inhibitors
  • Immune checkpoint inhibitors without angiogenesis inhibitors
  • Suzhou, Jiangsu, China
    The Affiliated Suzhou Hospital of Nanjing Medical University
Jan 17, 2023

Renal Cell Carcinoma Trial (Cytoreductive Nephrectomy)

Not yet recruiting
  • Renal Cell Carcinoma
  • Cytoreductive Nephrectomy
  • (no location specified)
Jul 3, 2023

Renal Cell Carcinoma Who Received First-Line Sunitinib

Completed
Has Results
  • Metastatic Renal Cell Carcinoma
  • Calgary, Alberta, Canada
    University of Calgary
Feb 19, 2021

Non Small Cell Lung Cancer Recurrent Trial (Toripalimab, Anlotinib and Chemotherapy)

Not yet recruiting
  • Non Small Cell Lung Cancer Recurrent
  • Toripalimab, Anlotinib and Chemotherapy
  • (no location specified)
Apr 24, 2023

B-cell Malignancies Undergoing Treatment With Bruton Tyrosine

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Non-Interventional Study
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 22, 2023

Newly Diagnosed Mantle Cell Lymphoma Trial in Zhengzhou (Rituximab)

Recruiting
  • Newly Diagnosed Mantle Cell Lymphoma
  • Zhengzhou, Henan, China
    Department of Oncology, The First Affiliated Hospital of Zhengzh
Aug 17, 2022

Skin Health and Quality of Life in Patients Receiving

Not yet recruiting
  • Lung Cancer
  • +7 more
  • EQ-5D-5L questionnaire
  • +2 more
  • Roma, Italy
    Roberto Iacovelli
May 17, 2023

Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Immune signature in serum associated to the metabolic signature
  • Meta-genomic signature of intestinal flora
  • La Tronche, Isère, France
    University Hospital, Grenoble
Jan 6, 2023

Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia Trial (HT-001 2% Topical Gel, HT-001 1% Topical Gel, HT-001 0.5%

Not yet recruiting
  • Acneiform Eruption Due to Chemical
  • +2 more
  • HT-001 2% Topical Gel
  • +3 more
  • (no location specified)
Dec 3, 2022

Immune Checkpoint Inhibitors in Genitourinary Malignancies

Suspended
  • Carcinoma, Renal Cell
  • Carcinoma, Urothelial
  • Immune cell and CTC detection procedures
  • Durham, North Carolina
    Duke University Medical Center
Nov 11, 2022

NSCLC Trial in GuangZhou (Aprepitant, Desloratadine, Placebo of aprepitant)

Completed
  • Non-small Cell Lung Cancer
  • GuangZhou, Guangdong, China
    Cancer Center of Sun-Yat Sen University (CCSYSU)
May 15, 2021

Combined Statin and PD-1/PD-L1 Inhibitors in Treating Non-small

Recruiting
  • Lung Cancer
  • Yiwu, Zhejiang, China
    The Fourth Affiliated Hospital of Zhejiang University
Dec 16, 2022

Non Small Cell Lung Cancer Trial in Brussels (FAPI PET/CT)

Recruiting
  • Non Small Cell Lung Cancer
  • FAPI PET/CT
  • Brussels, Belgium
    Institut Jules Bordet
Oct 24, 2023

Basal Cell Carcinoma, Radiotherapy; Complications Trial (radiation, other, drug)

Not yet recruiting
  • Basal Cell Carcinoma
  • Radiotherapy; Complications
  • Radiotherapy
  • +2 more
  • (no location specified)
Sep 30, 2022

NSCLC, Low Dose Radiotherapy, Stereotactic Body Radiotherapy Trial in Chengdu (Low Dose Radiotherapy, stereotactic body

Not yet recruiting
  • NSCLC
  • +3 more
  • Low Dose Radiotherapy
  • +2 more
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Nov 11, 2022

Renal Cell Carcinoma, Bladder Cancer, MSI-H Cancer Trial in Paris (Arterial Doppler for Flow Mediated Reserve measurement)

Recruiting
  • Renal Cell Carcinoma
  • +3 more
  • Arterial Doppler for Flow Mediated Reserve measurement
  • Paris, France
    INstitut Mutualiste Montsouris
Aug 29, 2023

Non Small Cell Lung Cancer Trial in Mexico City (Metformin Hydrochloride, Placebo)

Recruiting
  • Non Small Cell Lung Cancer
  • Metformin Hydrochloride
  • Placebo
  • Mexico City, Mexico
    Instituto Nacional de Cancerologia
Jul 21, 2022

r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase

Not yet recruiting
  • B-cell Lymphoma
  • Beijing, Beijing, China
    Deparment of Hematology, Peking University People's Hospital
Aug 9, 2022

NSCLC (NSCLC) Trial (Osimertinib, Amivantamab)

Not yet recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • (no location specified)
Mar 24, 2023